G Frick

1.4k total citations
47 papers, 1.1k citations indexed

About

G Frick is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, G Frick has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Physiology. Recurrent topics in G Frick's work include Growth Hormone and Insulin-like Growth Factors (14 papers), Adipose Tissue and Metabolism (9 papers) and DNA and Nucleic Acid Chemistry (6 papers). G Frick is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (14 papers), Adipose Tissue and Metabolism (9 papers) and DNA and Nucleic Acid Chemistry (6 papers). G Frick collaborates with scholars based in United States, Sweden and Germany. G Frick's co-authors include H. M. Goodman, John M. Lowenstein, Per-Åke Albertsson, Lennart Philipson, Sandra C. Souza, Per‐Åke Albertsson, Ray A. Olsson, Jerry A. Snow, Mary K. Gentry and Rupert G. Yip and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

G Frick

45 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Frick United States 17 438 335 200 133 127 47 1.1k
Yutaka Shizuta Japan 23 685 1.6× 552 1.6× 162 0.8× 50 0.4× 210 1.7× 46 1.6k
Yukichi Hara Japan 20 1.0k 2.3× 162 0.5× 139 0.7× 60 0.5× 105 0.8× 53 1.6k
Jean C. Ingram United Kingdom 18 755 1.7× 154 0.5× 119 0.6× 185 1.4× 547 4.3× 24 1.6k
J A Cortner United States 11 285 0.7× 229 0.7× 182 0.9× 29 0.2× 35 0.3× 16 836
Ronald A. Albright United States 11 1.0k 2.4× 308 0.9× 213 1.1× 73 0.5× 122 1.0× 12 1.3k
E. D. Wachsmuth Switzerland 19 552 1.3× 139 0.4× 100 0.5× 28 0.2× 239 1.9× 65 1.0k
G.L. Mills United Kingdom 21 420 1.0× 564 1.7× 123 0.6× 36 0.3× 61 0.5× 69 1.7k
Walburga Croteau United States 16 516 1.2× 668 2.0× 104 0.5× 58 0.4× 196 1.5× 20 1.4k
Esther Y. Chao United States 11 546 1.2× 87 0.3× 139 0.7× 90 0.7× 80 0.6× 15 881
Michael A. Reuben United States 16 681 1.6× 292 0.9× 60 0.3× 16 0.1× 127 1.0× 22 1.2k

Countries citing papers authored by G Frick

Since Specialization
Citations

This map shows the geographic impact of G Frick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Frick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Frick more than expected).

Fields of papers citing papers by G Frick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Frick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Frick. The network helps show where G Frick may publish in the future.

Co-authorship network of co-authors of G Frick

This figure shows the co-authorship network connecting the top 25 collaborators of G Frick. A scholar is included among the top collaborators of G Frick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Frick. G Frick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vu, Tuan, Renato Mantegazza, Djillali Annane, et al.. (2024). 506VP Long-term efficacy and safety of ravulizumab in adults with AChR-Ab+ gMG: final results from the phase 3 CHAMPION MG open-label extension. Neuromuscular Disorders. 43. 104441.639–104441.639.
2.
Frick, G, et al.. (2003). Interaction of the Growth Hormone Receptor with Cytokine-Induced Src Homology Domain 2 Protein in Rat Adipocytes. Endocrinology. 144(3). 868–876. 14 indexed citations
4.
Frick, G, et al.. (1998). Tissue Distribution, Turnover, and Glycosylation of the Long and Short Growth Hormone Receptor Isoforms in Rat Tissues*. Endocrinology. 139(6). 2824–2830. 37 indexed citations
6.
Bick, Tova, G Frick, Deborah M. Leonard, Jack L. Leonard, & H. M. Goodman. (1994). Overexpression of the Short Form of the Growth Hormone Receptor in 3T3-L1 Mouse Preadipocytes. Experimental Biology and Medicine. 206(3). 185–189. 3 indexed citations
7.
Souza, Sandra C., et al.. (1994). Growth hormone stimulates tyrosine phosphorylation of insulin receptor substrate-1.. Journal of Biological Chemistry. 269(48). 30085–30088. 100 indexed citations
8.
Goodman, H. M., et al.. (1994). The Significance of the Short Form of the Growth Hormone Receptor in Rat Adipocytes. Experimental Biology and Medicine. 206(3). 304–308. 3 indexed citations
9.
Frick, G. (1992). Characterization of the short isoform of the growth hormone receptor synthesized by rat adipocytes. Endocrinology. 131(6). 3083–3090. 9 indexed citations
10.
Frick, G, Jack L. Leonard, & H. M. Goodman. (1990). Effect of Hypophysectomy on Growth Hormone Receptor Gene Expression in Rat Tissues*. Endocrinology. 126(6). 3076–3082. 48 indexed citations
11.
Frick, G & H. M. Goodman. (1989). Insulin regulation of the activity and phosphorylation of branched-chain 2-oxo acid dehydrogenase in adipose tissue. Biochemical Journal. 258(1). 229–235. 20 indexed citations
12.
Frick, G, et al.. (1988). Transamination and oxidation of leucine and valine in rat adipose tissue.. Journal of Biological Chemistry. 263(7). 3245–3249. 6 indexed citations
13.
Frick, G, et al.. (1986). [Personal observations on the pathogenesis and therapy of headache syndromes].. PubMed. 80(1). 19–21.
14.
Frick, Andreas, et al.. (1980). Erste klinische und zystourethrotonometrische Ergebnisse nach einer neuen Modifikation der Marshall-Marchetti-Krantz-Operation. Geburtshilfe und Frauenheilkunde. 40(9). 784–790. 4 indexed citations
15.
Olsson, Ray A., et al.. (1973). Steric requirements for binding of adenosine to a membrane carrier in canine heart. Biochimica et Biophysica Acta (BBA) - Biomembranes. 311(2). 242–250. 13 indexed citations
16.
Olsson, Ray A., Jerry A. Snow, Mary K. Gentry, & G Frick. (1972). Adenosine Uptake by Canine Heart. Circulation Research. 31(5). 767–778. 63 indexed citations
17.
Philipson, Lennart, Per-Åke Albertsson, & G Frick. (1960). The purification and concentration of viruses by aqueous polymer phase systems. Virology. 11(3). 553–571. 89 indexed citations
18.
Frick, G. (1954). A study of the preparation of thymus nucleic acid according to Gulland et al.. Biochimica et Biophysica Acta. 13(1). 41–47. 5 indexed citations
19.
Frick, G. (1952). Formation of Amino-Acids in Hydrolysis of Adenine. Nature. 169(4305). 758–759. 5 indexed citations
20.
Frick, G. (1952). Thymo-nucleoproteins in NaCl solutions of different strengths. Biochimica et Biophysica Acta. 8. 202–210. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026